$25.17 $0.41 per serving
Product analysis
Coenzyme Q10 200 mg provides an affordable, simple option that may support some measures of blood-vessel function in selected adults. Evidence for fatigue relief is limited and depends on the preparation and people studied.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The CoQ10 is identified as ubiquinone, making its basic identity clear. The available information does not establish an absorption advantage for this preparation.
Ingredient Transparency100
Both the CoQ10 amount and its ubiquinone form are listed. That makes it easier to compare like-for-like preparations.
Value For Money100
The full serving offers favorable value for its ubiquinone content. The price comparison reflects conventional CoQ10 rather than an assumed delivery advantage.
Customer Satisfaction91
Customer feedback is strongly positive. A substantial review base supports confidence in that satisfaction pattern.
Product Focus79
The single ingredient has limited support for some heart-related measures and fatigue in selected settings. The broader goals do not establish a routine metabolism boost, fat loss or a longer life.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.41
- Also available
Coenzyme Q10 50 mg$18.17- Customer rating
- 4.8 · 4,913 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 has limited, preparation-specific evidence for fatigue relief. Its role in mitochondrial processes provides context, but does not by itself establish improved energy, and findings in disease populations cannot be generalized to routine healthy use. The declared ubiquinone preparation receives a contribution in the saved result; ubiquinol and ubiquinone amounts remain distinct, with no assumed absorption advantage.
How this product is rated for Energy
Ingredient fit93
The recognized ingredient is focused on its evaluated role, while the product is linked to several goals.
Goal fit
The recognized ingredient is focused on its evaluated role, while the product is linked to several goals.
Dose adequacy
The recognized amount reaches the saved reference; this does not establish an optimal dose, greater benefit or safety at higher exposure.
Pathways53
Mitochondrial energy production reaches the saved threshold; other energy areas receive no contribution.
Depth
The recognized contribution is concentrated in mitochondrial energy production; mechanisms alone do not establish a routine fatigue benefit.
Breadth
Mitochondrial energy production reaches the saved threshold; other energy areas receive no contribution.
Evidence84
Coenzyme Q10 drives the saved evidence finding, with limited preparation-specific fatigue support and no assumed form superiority.
Evidence strength
Coenzyme Q10 drives the saved evidence finding, with limited preparation-specific fatigue support and no assumed form superiority.
Studied preparation
The saved result recognizes the preparations meeting its amount threshold; this does not establish superiority or remove population and regimen limitations.
Formulation logic100
Recognized ingredients have no missing required partners, and no evaluated conflict was triggered. All meet the saved minimum amount threshold.
Partner coverage
Recognized ingredients work independently or have their required partners; no added combination benefit is established.
Conflicts
No configured ingredient conflict was triggered; this covers only the combinations evaluated.
Effective doses
All recognized ingredients meet the saved minimum amount threshold; this is not proof of a clinical energy response.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 has limited human findings for blood-vessel function, blood pressure and lipids in selected populations. The declared active CoQ10 amount is evaluated as conventional oral CoQ10, without assuming special delivery benefits. These findings do not establish prevention of heart attacks or other cardiovascular events. The serving meets the saved amount comparison fully.
How this product is rated for Heart Health
Ingredient fit93
Coenzyme Q-10 anchors the recognized ingredient fit; amounts fully meet the saved comparisons.
Goal fit
Coenzyme Q-10 is central to the recognized heart-health connection, though the product is linked to other goals.
Dose adequacy
The declared amount fully meets the saved exposure comparison; this does not establish a proven treatment dose.
Pathways60
The strongest saved coverage concerns endothelial nitric-oxide function, a limited marker-related connection rather than demonstrated event prevention.
Depth
The strongest saved coverage concerns endothelial nitric-oxide function, a limited marker-related connection rather than demonstrated event prevention.
Breadth
The saved breadth finding is concentrated in endothelial nitric-oxide function.
Evidence98
Coenzyme Q-10 supplies the strongest recognized evidence. Its human findings remain limited to the outcomes and populations described.
Evidence strength
Coenzyme Q-10 leads the recognized evidence, with the population and outcome limitations described for it.
Studied preparation
The saved findings accept the qualifying preparation; this does not establish delivery or form superiority.
Formulation logic100
No required partner is missing and no configured conflict applies. The recognized ingredients meet the saved minimum amount comparison.
Partner coverage
No required partner is missing for the recognized contributions.
Conflicts
No configured ingredient conflict was found; this does not establish individual suitability.
Effective doses
All recognized ingredients meet the saved minimum amount comparison; this threshold is not proof of clinical effectiveness.
Impact
Moderate effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 supports normal cellular energy production and antioxidant processes. The serving supplies 200 mg, but the supplied skin-aging evidence concerns a particular water-soluble preparation, making the connection to visible aging limited and preparation-specific. Longer lifespan is not a supported outcome.
How this product is rated for Longevity
Ingredient fit93
CoQ10 gives the formula a focused connection to cellular function.
Goal fit
CoQ10 is the main relevant active, with no unrelated actives reducing focus.
Dose adequacy
The serving reaches the saved upper amount comparison; higher amounts do not imply greater benefit.
Pathways40
Support is concentrated in cellular energy production, with a smaller antioxidant contribution.
Depth
Mitochondrial energy production is the strongest area.
Breadth
Only cellular energy production has substantial coverage.
Evidence30
The evidence contribution is modest and preparation-specific.
Evidence strength
CoQ10 provides the strongest saved evidence contribution.
Studied preparation
The declared CoQ10 is not matched to the studied preparation.
Formulation logic100
The relevant ingredients meet most amount comparisons without a flagged conflict.
Partner coverage
No required partner is missing.
Conflicts
No configured ingredient conflict was found.
Effective doses
The relevant ingredient meets the saved minimum amount comparison.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 may support selected blood-vessel function, blood-pressure or lipid markers. The supplied studies involved adults with abnormal lipids, including a small ubiquinol study in people with impaired vessel function, so broader benefits remain uncertain. These marker findings do not establish prevention of cardiovascular events or superiority of one CoQ10 form.
How this product is rated for Cardiovascular Support
Ingredient fit93
CoQ10 is the relevant active, with a complete saved amount finding.
Goal fit
The relevant active ingredients are central to the formula, though it is linked to several goals.
Dose adequacy
The included declared amount meets the saved amount finding; this is not a proven benefit threshold.
Pathways60
The saved findings are strongest for endothelial nitric-oxide function.
Depth
The strongest saved contribution concerns endothelial nitric-oxide function. This describes a selected mechanism rather than demonstrated event prevention.
Breadth
Only endothelial nitric-oxide function reaches the saved coverage criterion.
Evidence88
CoQ10 evidence supports selected markers in studied populations.
Evidence strength
CoQ10 has limited support for selected vascular or lipid markers in studied populations.
Studied preparation
The included preparations meet the saved preparation finding; this does not imply identical effects across populations or superior forms.
Formulation logic100
Partner requirements are satisfied and no matched conflicts were recorded; minimum amount findings vary by ingredient.
Partner coverage
No unmet partner requirement was recorded for the included ingredients; this does not establish extra benefit from combining them.
Conflicts
No matched formulation conflict was recorded in the supplied assessment.
Effective doses
The included ingredients meet the saved minimum amount criterion; it is not a proven effective clinical dose.
Impact
High effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 helps mitochondria transfer energy within cells. That role and studies of metabolic markers do not establish that supplementation increases whole-body energy expenditure in adults with adequate levels. The supplied evidence does not support a routine metabolism boost or a lasting fat-loss benefit from this serving.
How this product is rated for Metabolism Support
Ingredient fit93
Coenzyme Q10 relates to cellular energy handling, with full coverage of the supplied amount comparison.
Goal fit
Coenzyme Q10 is the sole recognized active relevant to cellular energy, though that does not demonstrate increased calorie expenditure.
Dose adequacy
The declared serving reaches the supplied amount comparison’s upper range, without demonstrating a larger metabolic effect.
Pathways54
Mitochondrial energy handling is the principal connection, without establishing increased whole-body calorie use.
Depth
The saved finding centers on mitochondrial energy handling, which does not itself show an increase in whole-body energy expenditure.
Breadth
Only mitochondrial energy and fat oxidation reach the supplied coverage threshold; other evaluated pathways do not.
Evidence75
Coenzyme Q10’s cellular role and metabolic-marker evidence support the saved finding, while evidence of routine increased energy expenditure remains lacking.
Evidence strength
Coenzyme Q10 supplies the evidence finding, but its cellular energy role and metabolic-marker studies do not demonstrate routine thermogenesis.
Studied preparation
The counted preparations match those recognized in the supplied comparison; this does not establish thermogenic benefit for the finished product.
Formulation logic100
No unmet partner requirement or specified conflict was identified. The counted ingredients meet the supplied minimum amount comparisons.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings; this does not establish additional benefit from combining them.
Conflicts
No specified ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients meet the supplied minimum amount comparison, which is not a demonstrated threshold for increased calorie expenditure.
Impact
High effect
Coenzyme Q-10 · 200 mg
Ubiquinone has limited relevance to inflammatory biomarkers in statin-treated coronary artery disease. A small trial used 300 mg daily for twelve weeks and found a TNF-alpha difference, while CRP and IL-6 were unchanged. The 200 mg label serving is below that study exposure, without establishing a proportionate clinical anti-inflammatory benefit.
How this product is rated for Inflammation
Ingredient fit80
Relevant ingredients receive recognition, with partial recognition of the serving amounts.
Goal fit
The retained relevant ingredient content is focused, while links to other goals do not establish anti-inflammatory effectiveness.
Dose adequacy
The serving receives partial recognition against the saved amount comparison; a smaller amount does not establish a proportionate clinical benefit.
Pathways46
Oxidative and mitochondrial stress is the strongest recorded pathway; biological relevance does not establish relief of inflammatory symptoms or disease.
Depth
Oxidative and mitochondrial stress is the strongest recorded pathway; biological relevance does not establish relief of inflammatory symptoms or disease.
Breadth
Only oxidative and mitochondrial stress reaches the saved coverage threshold; the other evaluated pathways do not.
Evidence93
CoQ10 leads the saved ingredient finding, but its supporting trial concerns limited biomarkers in statin-treated coronary disease.
Evidence strength
CoQ10 leads the saved ingredient finding, but its supporting trial concerns limited biomarkers in statin-treated coronary disease.
Studied preparation
The retained preparations receive recognition in the saved finding; this does not establish equivalence across forms or a proven daily treatment regimen.
Formulation logic100
No required partners are missing and no configured conflicts were matched. Recognition of serving amounts does not establish clinical effectiveness.
Partner coverage
No required partner is missing for ingredients receiving a contribution; this does not establish additional benefit from combining them.
Conflicts
No configured ingredient conflict was matched in the supplied facts.
Effective doses
All retained ingredients clear the saved minimum amount check; that threshold is not a proven clinically effective dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q10 (Ubiquinone) | 200 mg |
Coenzyme Q-10 (Ubiquinone) · 200 mg OverallScore79
Each serving provides 200 mg of CoQ10 as ubiquinone, an amount that aligns well with the evaluation. At about $0.21 per 100 mg, it is competitively priced for the form.
How this ingredient is rated
Active Ingredient Quality & Bioavailability48
The CoQ10 is ubiquinone; no special delivery system or black pepper enhancer is recorded.
Molecular Form: Ubiquinol vs. Ubiquinone
CoQ10 is ubiquinone, a form the body converts to ubiquinol.
Formulation & Absorption Enhancers
No advanced delivery system or black pepper enhancer is recorded in the saved facts.
Dose, Safety & Label Transparency100
Each serving provides 200 mg of CoQ10, with no specified additives or standard fillers flagged in the evaluation.
Clinical Dosage Alignment
The 200 mg per serving aligns well with the evaluation for ubiquinone.
Label Transparency & Fillers
The amount is disclosed, and the evaluation flags neither the specified additives nor standard fillers.
Value100
At about $0.21 per 100 mg, the ubiquinone is competitively priced in the evaluation.
Price Per Effective Serving
At about $0.21 per 100 mg, the ubiquinone is competitively priced in the evaluation.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.